Suppr超能文献

医疗保险优势对医院再入院率和死亡率排名的影响。

Effect of Medicare Advantage on Hospital Readmission and Mortality Rankings.

机构信息

Section of Health Policy and Equity at the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, and Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts (A.S.O.).

Section of Health Policy and Equity at the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts (R.K.W.).

出版信息

Ann Intern Med. 2023 Apr;176(4):480-488. doi: 10.7326/M22-3165. Epub 2023 Mar 28.

Abstract

BACKGROUND

Medicare links hospital performance on readmissions and mortality to payment solely on the basis of outcomes among fee-for-service (FFS) beneficiaries. Whether including Medicare Advantage (MA) beneficiaries, who account for nearly half of all Medicare beneficiaries, in the evaluation of hospital performance affects rankings is unknown.

OBJECTIVE

To determine if the inclusion of MA beneficiaries in readmission and mortality measures reclassifies hospital performance rankings compared with current measures.

DESIGN

Cross-sectional.

SETTING

Population-based.

PARTICIPANTS

Hospitals participating in the Hospital Readmissions Reduction Program or Hospital Value-Based Purchasing Program.

MEASUREMENTS

Using the 100% Medicare files for FFS and MA claims, the authors calculated 30-day risk-adjusted readmissions and mortality for acute myocardial infarction, heart failure, chronic obstructive pulmonary disease, and pneumonia on the basis of only FFS beneficiaries and then both FFS and MA beneficiaries. Hospitals were divided into quintiles of performance based on FFS beneficiaries only, and the proportion of hospitals that were reclassified to a different performance group with the inclusion of MA beneficiaries was calculated.

RESULTS

Of the hospitals in the top-performing quintile for readmissions and mortality based on FFS beneficiaries, between 21.6% and 30.2% were reclassified to a lower-performing quintile with the inclusion of MA beneficiaries. Similar proportions of hospitals were reclassified from the bottom performance quintile to a higher one across all measures and conditions. Hospitals with a higher proportion of MA beneficiaries were more likely to improve in performance rankings.

LIMITATION

Hospital performance measurement and risk adjustment differed slightly from those used by Medicare.

CONCLUSION

Approximately 1 in 4 top-performing hospitals is reclassified to a lower performance group when MA beneficiaries are included in the evaluation of hospital readmissions and mortality. These findings suggest that Medicare's current value-based programs provide an incomplete picture of hospital performance.

PRIMARY FUNDING SOURCE

Laura and John Arnold Foundation.

摘要

背景

医疗保险仅根据服务收费(FFS)受益人的结果将医院的再入院率和死亡率与支付挂钩。将医疗保险优势(MA)受益人纳入医院绩效评估中,是否会影响排名尚不清楚,而这些受益人几乎占所有医疗保险受益人的一半。

目的

确定将 MA 受益人纳入再入院和死亡率评估中是否会重新分类与当前评估相比的医院绩效排名。

设计

横断面。

设置

基于人群。

参与者

参与医院再入院减少计划或医院价值购买计划的医院。

测量方法

作者使用 FFS 和 MA 索赔的 100%医疗保险档案,根据仅 FFS 受益人和 FFS 和 MA 受益人均计算了急性心肌梗死、心力衰竭、慢性阻塞性肺疾病和肺炎的 30 天风险调整再入院率和死亡率。根据仅 FFS 受益人的数据,将医院分为绩效五分位数,然后计算纳入 MA 受益人的情况下,有多少医院被重新分类到不同的绩效组。

结果

在基于 FFS 受益人的再入院和死亡率表现最佳的五分位数中,约有 21.6%至 30.2%的医院在纳入 MA 受益人的情况下被重新分类为表现较低的五分位数。在所有措施和情况下,从表现最差的五分位数重新分类到表现较高的五分位数的医院比例相似。MA 受益人的比例较高的医院更有可能提高绩效排名。

局限性

医院绩效衡量和风险调整与医疗保险使用的方法略有不同。

结论

当将 MA 受益人纳入医院再入院和死亡率评估时,大约四分之一的表现最佳的医院被重新分类为表现较差的群体。这些发现表明,医疗保险目前的基于价值的计划提供了医院绩效的不完整图景。

主要资金来源

劳拉和约翰·阿诺德基金会。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验